FDA Determines Regulatory Review Period for CERENIA INJECTABLE SOLUTION Patent Extension Application

Summary

The Food and Drug Administration (FDA) has determined the regulatory review period for CERENIA INJECTABLE SOLUTION, a veterinary drug, and is publishing this notice as required by law. The FDA made this determination due to a patent extension application submitted to the Director of Patents and Trademarks at the US Department of Commerce.